Stock PHARMAID PHARMAIDS PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharmaids Pharmaceuticals Limited

Equities

PHARMAID

INE117D01018

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:52:20 04/06/2024 pm IST 		5-day change 1st Jan Change
53.62 INR +1.78% Intraday chart for Pharmaids Pharmaceuticals Limited -7.54% +10.15%
28/05 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
28/05 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 9.229 16.04 46.4 115.3 129 488.8
Enterprise Value (EV) 1 7.395 14.97 46.18 113.3 124.9 328.2
P/E ratio -2.39 x -8.68 x 150 x 124 x 89.4 x -3.72 x
Yield - - - - - -
Capitalization / Revenue 2.05 x 3.33 x - 1.35 x 3.27 x -
EV / Revenue 1.65 x 3.11 x - 1.32 x 3.17 x -
EV / EBITDA -1.92 x -9.92 x -13.8 x 106 x 91.1 x -3.45 x
EV / FCF -853 x -11.4 x 1.33 x 32 x 37 x -4.61 x
FCF Yield -0.12% -8.79% 75.5% 3.13% 2.71% -21.7%
Price to Book 0.89 x 1.87 x 0.55 x 1.35 x 1.49 x 2.09 x
Nbr of stocks (in thousands) 3,406 3,406 10,311 10,311 10,311 22,411
Reference price 2 2.710 4.710 4.500 11.18 12.51 21.81
Announcement Date 13/08/18 31/08/19 21/08/20 30/08/21 23/07/22 31/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 4.491 4.81 - 85.51 39.39 -
EBITDA 1 -3.862 -1.51 -3.355 1.069 1.371 -95.2
EBIT 1 -3.872 -1.524 -3.743 0.6209 1.279 -95.37
Operating Margin -86.22% -31.69% - 0.73% 3.25% -
Earnings before Tax (EBT) 1 -3.686 -1.477 -3.752 0.8843 1.403 -99.08
Net income 1 -3.857 -1.847 0.3353 0.9331 1.451 -75.56
Net margin -85.88% -38.4% - 1.09% 3.68% -
EPS 2 -1.133 -0.5423 0.0300 0.0900 0.1400 -5.860
Free Cash Flow 1 -0.008668 -1.316 34.85 3.542 3.381 -71.24
FCF margin -0.19% -27.36% - 4.14% 8.58% -
FCF Conversion (EBITDA) - - - 331.25% 246.59% -
FCF Conversion (Net income) - - 10,392.87% 379.57% 232.91% -
Dividend per Share - - - - - -
Announcement Date 13/08/18 31/08/19 21/08/20 30/08/21 23/07/22 31/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.83 1.07 0.22 2 4.07 161
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.01 -1.32 34.9 3.54 3.38 -71.2
ROE (net income / shareholders' equity) -31.2% -19.4% 0.4% 1.1% 1.69% -48.5%
ROA (Net income/ Total Assets) -14.6% -8.15% -2.73% 0.44% 0.79% -33.4%
Assets 1 26.42 22.66 -12.27 211.3 183.7 226.3
Book Value Per Share 2 3.060 2.520 8.180 8.270 8.410 10.50
Cash Flow per Share 2 0.6900 0.3100 0.0200 0.1900 0.4000 5.940
Capex 1 0.03 0.02 0.42 0.02 - 16.7
Capex / Sales 0.74% 0.35% - 0.02% - -
Announcement Date 13/08/18 31/08/19 21/08/20 30/08/21 23/07/22 31/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PHARMAIDS PHARMACEUTICALS LIMITED Stock Pharmaids Pharmaceuticals Limited
+10.15% 22.35M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.60% 748B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+33.78% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.74% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.79% 325B
ABBVIE INC. Stock AbbVie Inc.
+3.37% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.17% 245B
NOVARTIS AG Stock Novartis AG
+9.39% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-3.76% 209B
PFIZER, INC. Stock Pfizer, Inc.
+1.81% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PHARMAID Stock
  4. Financials Pharmaids Pharmaceuticals Limited